MedPath

A Clinical Study To Evaluate The Efficacy of Ayurvedic Drug In The Treatment Of BPH (Benign Prostate Hyperplasia)

Phase 2
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2024/07/071543
Lead Sponsor
Dr Rushda Nazir Ahmed Karjikar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients with mild and moderate symptoms as per American Urological Association score (IPSS) given for BPH.

2) Patients having samanya lakshana(Symptoms) of Vatashthila(BPH).

3) Patients will be included irrespective of their caste, religion, economic status, occupation.

4) Patients only those who are ready to give written consent will be selected.

Exclusion Criteria

1) Patients having – Acute urinary retention, Stricture of Urethra, Carcinoma of Prostate, Bladder polyp, Hydronephrosis, Congenital contracture of Bladder neck, Carcinoma of Urinary tract, Neurogenic bladder.

2) Patients with severe systemic diseases like- Renal failure, Cardiovascular disorders, uncontrolled diabetes mellitus and hypertension, Tuberculosis, HIV- Immuno compromised patients.

3) Patients those who are not ready to give written consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of Devdarvyadi Churna in the management of Vatashthila w.s.r to BPHTimepoint: 90 days study with <br/ ><br>Follow-up on- 15th ,30th ,90th day
Secondary Outcome Measures
NameTimeMethod
1) To study the etiopathogenesis of Vatashthila w.s.r to BPH <br/ ><br>2)To study the Literature of Devdarvyadi ChurnaTimepoint: 90 days study with <br/ ><br>Follow-up on- 15th ,30th ,90th day
© Copyright 2025. All Rights Reserved by MedPath